Emmaus Life Sciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-1.3M | $-1.3M | $73.0K | $553.0K |
| FY2022 | $-5.1M | $-5.1M | $26.0K | $16.0K |
| FY2023 | $-1.5M | $-1.5M | $17.0K | $1.3M |
| FY2024 | $-2.3M | $-2.3M | $12.0K | $256.0K |
| FY2025 | $-11.0K | $-12.0K | $1.0K | $25.0K |